{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:38:26Z","timestamp":1777455506863,"version":"3.51.4"},"reference-count":69,"publisher":"Hindawi Limited","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1447,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Mutat."],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1002\/humu.21561","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T17:42:22Z","timestamp":1311788542000},"page":"1246-1258","source":"Crossref","is-referenced-by-count":21,"title":["A gain-of-glycosylation mutation associated with myoclonus-dystonia syndrome affects trafficking and processing of mouse \u03b5-sarcoglycan in the late secretory pathway"],"prefix":"10.1155","volume":"32","author":[{"given":"Adrian","family":"Waite","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Brancaccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek J.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2011,9,15]]},"reference":[{"key":"10.1002\/humu.21561-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1084\/jem.20051342","article-title":"Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis","volume":"203","author":"Agrawal","year":"2006","journal-title":"J Exp Med"},{"key":"10.1002\/humu.21561-BIB2|cit2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1021185627968","article-title":"An ischemic beta-dystroglycan (betaDG) degradation product: correlation with irreversible injury in adult rabbit cardiomyocytes","volume":"242","author":"Armstrong","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1002\/humu.21561-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1093\/brain\/awm209","article-title":"Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype","volume":"130","author":"Asmus","year":"2007","journal-title":"Brain"},{"key":"10.1002\/humu.21561-BIB4|cit4","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ana.20661","article-title":"Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene","volume":"58","author":"Asmus","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1002\/humu.21561-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/hmg\/ddn029","article-title":"Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation","volume":"17","author":"Bartoli","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21561-BIB6|cit6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrg2520","article-title":"Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations","volume":"10","author":"Bateman","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1002\/humu.21561-BIB7|cit7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and genetics of dystrophin and dystrophin-related proteins in muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1002\/humu.21561-BIB8|cit8","doi-asserted-by":"crossref","first-page":"44812","DOI":"10.1074\/jbc.C400353200","article-title":"The structure of the N-terminal region of murine skeletal muscle alpha-dystroglycan discloses a modular architecture","volume":"279","author":"Bozic","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21561-BIB9|cit9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.matbio.2009.03.003","article-title":"Functional diversity of dystroglycan","volume":"28","author":"Bozzi","year":"2009","journal-title":"Matrix Biol"},{"key":"10.1002\/humu.21561-BIB10|cit10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrn2337","article-title":"The pathophysiological basis of dystonias","volume":"9","author":"Breakefield","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1002\/humu.21561-BIB11|cit11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1126\/science.1198461","article-title":"Protein native-state stabilization by placing aromatic side chains in N-glycosylated reverse turns","volume":"331","author":"Culyba","year":"2011","journal-title":"Science"},{"key":"10.1002\/humu.21561-BIB12|cit12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajmg.a.20162","article-title":"Myoclonus in a patient with a deletion of the epsilon-sarcoglycan locus on chromosome 7q21","volume":"121A","author":"DeBerardinis","year":"2003","journal-title":"Am J Med Genet"},{"key":"10.1002\/humu.21561-BIB13|cit13","doi-asserted-by":"crossref","first-page":"R197","DOI":"10.1016\/S0960-9822(02)00748-0","article-title":"Cadherin-like domains in alpha-dystroglycan, alpha\/epsilon-sarcoglycan and yeast and bacterial proteins","volume":"12","author":"Dickens","year":"2002","journal-title":"Curr Biol"},{"key":"10.1002\/humu.21561-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/WNL.59.8.1187","article-title":"Phenotypic features of myoclonus-dystonia in three kindreds","volume":"59","author":"Doheny","year":"2002","journal-title":"Neurology"},{"key":"10.1002\/humu.21561-BIB15|cit15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mus.20640","article-title":"The beta-delta-core of sarcoglycan is essential for deposition at the plasma membrane","volume":"34","author":"Draviam","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1002\/humu.21561-BIB16|cit16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0959-437X(02)00309-X","article-title":"Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models","volume":"12","author":"Durbeej","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"10.1002\/humu.21561-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1126\/science.286.5446.1882","article-title":"Setting the standards: quality control in the secretory pathway","volume":"286","author":"Ellgaard","year":"1999","journal-title":"Science"},{"key":"10.1002\/humu.21561-BIB18|cit18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/hmg\/ddl472","article-title":"SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA","volume":"16","author":"Esapa","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21561-BIB19|cit19","doi-asserted-by":"crossref","first-page":"32534","DOI":"10.1074\/jbc.272.51.32534","article-title":"epsilon-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D [published erratum appears in J Biol Chem 1998 Jul 31;273(31):19922]","volume":"272","author":"Ettinger","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21561-BIB20|cit20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/WNN.0b013e3181a7228f","article-title":"Is psychopathology part of the phenotypic spectrum of myoclonus-dystonia?: a study of a large Dutch M-D family","volume":"22","author":"Foncke","year":"2009","journal-title":"Cogn Behav Neurol"},{"key":"10.1002\/humu.21561-BIB21|cit21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2353\/ajpath.2008.071146","article-title":"Inhibition of proteasome activity promotes the correct localization of disease-causing alpha-sarcoglycan mutants in HEK-293 cells constitutively expressing beta-, gamma-, and delta-sarcoglycan","volume":"173","author":"Gastaldello","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1002\/humu.21561-BIB22|cit22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/01.wnl.0000201192.66467.a3","article-title":"Phenotype-genotype correlation in Dutch patients with myoclonus-dystonia","volume":"66","author":"Gerrits","year":"2006","journal-title":"Neurology"},{"key":"10.1002\/humu.21561-BIB23|cit23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.mcn.2008.09.004","article-title":"Constitutive, agonist-accelerated, recycling and lysosomal degradation of GABA(B) receptors in cortical neurons","volume":"39","author":"Grampp","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"10.1002\/humu.21561-BIB24|cit24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/humu.9521","article-title":"Myoclonus-dystonia: significance of large SGCE deletions","volume":"29","author":"Grunewald","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.21561-BIB25|cit25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1097-0029(20000201\/15)48:3\/4<167::AID-JEMT5>3.0.CO;2-T","article-title":"Sarcoglycans in muscular dystrophy","volume":"48","author":"Hack","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1002\/humu.21561-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/01.WNL.0000118286.75059.35","article-title":"Myoclonus-dystonia: detection of novel, recurrent, and de novo SGCE mutations","volume":"62","author":"Hedrich","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/humu.21561-BIB27|cit27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1468-1331.2008.02116.x","article-title":"No muscle involvement in myoclonus-dystonia caused by epsilon-sarcoglycan gene mutations","volume":"15","author":"Hjermind","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1002\/humu.21561-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/01.WNL.0000061480.86610.BF","article-title":"A novel mutation in the epsilon-sarcoglycan gene causing myoclonus-dystonia syndrome","volume":"60","author":"Hjermind","year":"2003","journal-title":"Neurology"},{"key":"10.1002\/humu.21561-BIB29|cit29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/hmg\/ddi072","article-title":"Epsilon-sarcoglycan compensates for lack of alpha-sarcoglycan in a mouse model of limb-girdle muscular dystrophy","volume":"14","author":"Imamura","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21561-BIB30|cit30","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/bip.360221211","article-title":"Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features","volume":"22","author":"Kabsch","year":"1983","journal-title":"Biopolymers"},{"key":"10.1002\/humu.21561-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00424-007-0364-6","article-title":"Missorting of the Aquaporin-2 mutant E258K to multivesicular bodies\/lysosomes in dominant NDI is associated with its monoubiquitination and increased phosphorylation by PKC but is due to the loss of E258","volume":"455","author":"Kamsteeg","year":"2008","journal-title":"Pflugers Arch"},{"key":"10.1002\/humu.21561-BIB32|cit32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cell.2004.06.003","article-title":"Molecular recognition by LARGE is essential for expression of functional dystroglycan","volume":"117","author":"Kanagawa","year":"2004","journal-title":"Cell"},{"key":"10.1002\/humu.21561-BIB33|cit33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.22425","article-title":"Myoclonus-dystonia: an update","volume":"24","author":"Kinugawa","year":"2009","journal-title":"Mov Disord"},{"key":"10.1002\/humu.21561-BIB34|cit34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/ana.10358","article-title":"Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations","volume":"52","author":"Klein","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1002\/humu.21561-BIB35|cit35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s100480100111","article-title":"Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism","volume":"3","author":"Leung","year":"2001","journal-title":"Neurogenetics"},{"key":"10.1002\/humu.21561-BIB36|cit36","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1523\/JNEUROSCI.0346-04.2004","article-title":"A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization","volume":"24","author":"Li","year":"2004","journal-title":"J Neurosci"},{"key":"10.1002\/humu.21561-BIB37|cit37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0014-5793(00)02157-8","article-title":"Anomalous dystroglycan in carcinoma cell lines","volume":"484","author":"Losasso","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1002\/humu.21561-BIB38|cit38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/356083a0","article-title":"Assessment of protein models with three-dimensional profiles","volume":"356","author":"Luthy","year":"1992","journal-title":"Nature"},{"key":"10.1002\/humu.21561-BIB39|cit39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajmg.b.10062","article-title":"Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation","volume":"119B","author":"Marechal","year":"2003","journal-title":"Am J Med Genet"},{"key":"10.1002\/humu.21561-BIB40|cit40","doi-asserted-by":"crossref","first-page":"16036","DOI":"10.1074\/jbc.M700641200","article-title":"Beta-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity","volume":"282","author":"Michaluk","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21561-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/mds.21297","article-title":"Myoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the epsilon-sarcoglycan gene","volume":"22","author":"Misbahuddin","year":"2007","journal-title":"Mov Disord"},{"issue":"Pt 3","key":"10.1002\/humu.21561-BIB42|cit42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1242\/jcs.112.3.329","article-title":"Agonist-induced sorting of human beta2-adrenergic receptors to lysosomes during downregulation","volume":"112","author":"Moore","year":"1999","journal-title":"J Cell Sci"},{"key":"10.1002\/humu.21561-BIB43|cit43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/prot.340120407","article-title":"Stereochemical quality of protein structure coordinates","volume":"12","author":"Morris","year":"1992","journal-title":"Proteins"},{"key":"10.1002\/humu.21561-BIB44|cit44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/mds.21715","article-title":"Myoclonus-dystonia syndrome: clinical presentation, disease course, and genetic features in 11 families","volume":"23","author":"Nardocci","year":"2008","journal-title":"Mov Disord"},{"key":"10.1002\/humu.21561-BIB45|cit45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-5793(96)01134-9","article-title":"L273S missense substitution in human lysosomal acid lipase creates a new N-glycosylation site","volume":"397","author":"Pariyarath","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1002\/humu.21561-BIB46|cit46","doi-asserted-by":"crossref","DOI":"10.1002\/mds.23791","article-title":"Psychiatric disorders, myoclonus dystonia and the epsilon-sarcoglycan gene: a systematic review","author":"Peall","year":"2011","journal-title":"Mov Disord in press."},{"key":"10.1002\/humu.21561-BIB47|cit47","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1128\/MCB.20.9.3308-3315.2000","article-title":"Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: identification by a subtractive screen of novel uniparental fibroblast lines","volume":"20","author":"Piras","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1002\/humu.21561-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.yexcr.2008.09.020","article-title":"Trafficking and function of the tetraspanin CD63","volume":"315","author":"Pols","year":"2009","journal-title":"Exp Cell Res"},{"key":"10.1002\/humu.21561-BIB49|cit49","doi-asserted-by":"crossref","DOI":"10.1002\/mds.21785","article-title":"Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations","author":"Raymond","year":"2008","journal-title":"Mov Disord 23:588-592"},{"key":"10.1002\/humu.21561-BIB50|cit50","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.2008.162099","article-title":"Myoclonus-dystonia: clinical and genetic evaluation of a large cohort","author":"Ritz","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry 80:653-658"},{"key":"10.1002\/humu.21561-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1212\/01.wnl.0000297516.98574.c0","article-title":"Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations","volume":"70","author":"Roze","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/humu.21561-BIB52|cit52","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2008.01.006","article-title":"Processing and secretion of the N-terminal domain of alpha-dystroglycan in cell culture media","volume":"582","author":"Saito","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1002\/humu.21561-BIB53|cit53","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J Mol Biol"},{"key":"10.1002\/humu.21561-BIB54|cit54","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1017\/S1462399409001203","article-title":"Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects","volume":"11","author":"Sandona","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"10.1002\/humu.21561-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/jnnp.2003.027177","article-title":"Genetic heterogeneity in ten families with myoclonus-dystonia","volume":"75","author":"Schule","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/humu.21561-BIB56|cit56","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1083\/jcb.200312018","article-title":"Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes","volume":"164","author":"Sharma","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1002\/humu.21561-BIB57|cit57","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1158\/0008-5472.CAN-04-1638","article-title":"Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells","volume":"64","author":"Singh","year":"2004","journal-title":"Cancer Res"},{"key":"10.1002\/humu.21561-BIB58|cit58","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/bioinformatics\/bti125","article-title":"Protein homology detection by HMM-HMM comparison","volume":"21","author":"Soding","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1002\/humu.21561-BIB59|cit59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1083\/jcb.101.2.531","article-title":"Effect of lysosomotropic amines on the secretory pathway and on the recycling of the asialoglycoprotein receptor in human hepatoma cells","volume":"101","author":"Strous","year":"1985","journal-title":"J Cell Biol"},{"key":"10.1002\/humu.21561-BIB60|cit60","article-title":"Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes","author":"Tezenas du Montcel","year":"2006","journal-title":"J Med Genet 43:394-400"},{"key":"10.1002\/humu.21561-BIB61|cit61","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/ng1581","article-title":"Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations","volume":"37","author":"Vogt","year":"2005","journal-title":"Nat Genet."},{"key":"10.1002\/humu.21561-BIB62|cit62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.gde.2007.04.008","article-title":"Gain-of-glycosylation mutations","volume":"17","author":"Vogt","year":"2007","journal-title":"Curr Opin Genet Dev"},{"key":"10.1002\/humu.21561-BIB63|cit63","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/07853890802668522","article-title":"The neurobiology of the dystrophin-associated glycoprotein complex","volume":"41","author":"Waite","year":"2009","journal-title":"Ann Med"},{"key":"10.1002\/humu.21561-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/hmg\/10.15.1563","article-title":"Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex","volume":"10","author":"Yamada","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21561-BIB65|cit65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jb\/mvj138","article-title":"Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in varepsilon-sarcoglycan deficient mice","volume":"140","author":"Yokoi","year":"2006","journal-title":"J Biochem (Tokyo)"},{"key":"10.1002\/humu.21561-BIB66|cit66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jb\/mvq078","article-title":"Earlier onset of motor deficits in mice with double mutations in Dyt1 and Sgce","volume":"148","author":"Yokoi","year":"2010","journal-title":"J Biochem"},{"key":"10.1002\/humu.21561-BIB67|cit67","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1007\/s00018-009-0121-4","article-title":"Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease","volume":"66","author":"Zhang","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1002\/humu.21561-BIB68|cit68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2105-9-40","article-title":"I-TASSER server for protein 3D structure prediction","volume":"9","author":"Zhang","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1002\/humu.21561-BIB69|cit69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng709","article-title":"Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome","volume":"29","author":"Zimprich","year":"2001","journal-title":"Nat Genet"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.21561","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/humu.21561\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T16:54:32Z","timestamp":1672332872000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.21561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,15]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1002\/humu.21561","relation":{},"ISSN":["1059-7794"],"issn-type":[{"value":"1059-7794","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9,15]]}}}